Statistical Analysis of Competing Risks: Overall Survival in a Group of Chronic Myeloid Leukemia Patients

نویسندگان

  • Jana Fürstová
  • Zdeněk Valenta
چکیده

Background: Survival analysis is a collection of statistical methods for inference on time-to-event data. If several causes of failure occur and the occurrence of one event precludes the occurrence of the other events, the situation is known as competing risks. Since the competing risks violate the fundamental assumption of independent censoring, specific methods for inference are needed. Objectives: The aim of this paper is to recall the competing risks model and statistical methods for nonparametric analysis, and to illustrate the competing risks methods on a real data set of 118 Chronic Myeloid Leukemia (CML) patients from the Clinic of Haemato-oncology of the University Hospital in Olomouc. Methods: The overall survival probability and risk factors of two types of failure (death due to CML and death from other causes) are assessed. Predicted probabilities of the two types of failure with stratification based on the risk factors (Sokal score, haematological response to treatment) are shown. Results: Outcomes of the specific methods designed for the competing risks analysis are compared with the outcomes of the standard survival analysis methods. The effect of the Sokal score classification is found ambiguous. While the score should identify highand low-risk CML patients, it seems to be predictive only for the failure due to other causes than CML. Mgr. Jana Fürstová Conclusions: The importance of careful censoring and the need of using proper methods of analyses of competing risks data is shown. The use of the Sokal score for classification of the CML patients should be considered more thoroughly.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی عوامل خطر بر زمان بقای لوسمی حاد کودکان با استفاده از مدل ریسک رقابتی

Background and purpose: Acute leukemia is a malignancy with a rapidly progressive course of the lymphoid or myeloid cells. A prognostic factor for its survival and treatment is of particular importance in medical research. Therefore, this study aimed at applying competing risk model to compare clinical and pathologic factors in pediatric acute leukemia. Materials and methods: A historical coho...

متن کامل

Determining factors contributing to the five-year survival of children suffering from acute lymphoblastic leukemia based on tree survival model in the presence of competing risks

Abstract Background and objectives: Leukemia is one of the most prevalent cancers worldwide. The relapse of the disease mitigates patient survival time. The convenience of explaining the results obtained from analyzing tree models have encouraged doctors and paramedics to employ them in their research. The current study is an attempt to determine the five-year survival time and factors influen...

متن کامل

تعیین عوامل موثر بر بقای کودکان مبتلا به لوسمی لنفوبلاستیک حاد با استفاده از مدل خطرات رقیب

Background and Objective: Acute lymphoblastic leukemia (ALL) is the most common malignancy in children, accounting for about a quarter of all malignancies. This study aimed to identify the prognosis of patients with relapsed acute lymphoblastic leukemia in Dr. Sheikh Hospital in Mashhad from 2006 to 2015 using competing risk models. Materials and Methods: Patients with ALL from March 2006 to...

متن کامل

Analysis of Expression Of SIRT1 Gene In Patients With Chronic Myeloid Leukemia Resistant To Imatinib Mesylate

Background: Chronic myeloid leukemia is a clonal myeloproliferative disease which is characterized by bcr/abl translocation. With the emergence of tyrosine kinase inhibitors such as imatinib mesylate, significant improvement has been made in treatment of this disease. However, drug resistance against this medicine is still an obstacle. SIRT1 is a gene with deacetylase activity which has been de...

متن کامل

Preliminary Results of Allogenic Hematopoietic Stem Cell Transplantation of non-M3 Acute Myeloid Leukemia

Background:  Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is used as treatment of choice for patients with acute myeloid leukemia (AML). We aimed to evaluate the prognostic factors in 2-year overall survival of patients with non-M3 AML who underwent allogenic HSCT. Methods: This is a Cross sectional retrospective study. Demographic data and study of variables such as age...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011